Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,455 public trials 324 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

NCT01058863

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Clinical Study Site Huntington Beach, California, United States
  • Teva Clinical Study Site Rolling Hills Est., California, United States
  • Teva Clinical Study Site San Diego, California, United States
  • Teva Clinical Study Site Colorado Springs, Colorado, United States
View all 13 locations
View Trial Details
Completed

An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils

NCT02501629

Conditions
Asthma, Bronchial Diseases, Elevated Blood Eosinophils, +8 more
Locations
  • Teva Investigational Site 13357 Bakersfield, California, United States
  • Teva Investigational Site 13365 Long Beach, California, United States
  • Teva Investigational Site 13371 Clermont, Florida, United States
  • Teva Investigational Site 13351 Homestead, Florida, United States
View all 127 locations
View Trial Details
Completed

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

NCT02437604

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 13178 Raleigh, North Carolina, United States
  • Teva Investigational Site 13177 Edmond, Oklahoma, United States
  • Teva Investigational Site 13179 San Antonio, Texas, United States
View Trial Details
Completed

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

NCT02969408

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 13964 Litchfield Park, Arizona, United States
  • Teva Investigational Site 13959 Bakersfield, California, United States
  • Teva Investigational Site 13954 Los Angeles, California, United States
  • Teva Investigational Site 13923 Orange, California, United States
View all 44 locations
View Trial Details
Completed

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics

NCT02126839

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12496 Birmingham, Alabama, United States
  • Teva Investigational Site 12500 Mobile, Alabama, United States
  • Teva Investigational Site 12481 Little Rock, Alaska, United States
  • Teva Investigational Site 12515 Anaheim, California, United States
View all 52 locations
View Trial Details
Completed

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

NCT02040766

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12346 Hoover, Alabama, United States
  • Teva Investigational Site 12294 Montgomery, Alabama, United States
  • Teva Investigational Site 10925 Phoenix, Arizona, United States
  • Teva Investigational Site 12349 Little Rock, Arkansas, United States
View all 102 locations
View Trial Details
Completed

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

NCT02980133

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 13881 Birmingham, Alabama, United States
  • Teva Investigational Site 13883 Little Rock, Arkansas, United States
  • Teva Investigational Site 13906 Bakersfield, California, United States
  • Teva Investigational Site 14615 Corona, California, United States
View all 118 locations
View Trial Details
Completed

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

NCT02141854

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12429 Birmingham, Alabama, United States
  • Teva Investigational Site 12599 Little Rock, Alaska, United States
  • Teva Investigational Site 12609 Phoenix, Arizona, United States
  • Teva Investigational Site 12445 Costa Mesa, California, United States
View all 154 locations
View Trial Details

Related conditions